Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Myotonic Dystrophy

• A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)
• Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy
• Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)
• Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1
• Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients
• Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients
• Safety and Efficacy of Tideglusib in Congenital Myotonic Dystrophy
• Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1
• Study to Investigate the Efficacy and Safety of Mexiletine in Patients With Myotonic Dystrophy Type 1 and Type 2
• Open Label Study in Adolescents and Children With Myotonic Disorders
• Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1
• Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy
• Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy
• A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1
• Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
• Lamotrigine as Treatment of Myotonia
• Methylphenidate in Myotonic Dystrophy Type 1
• Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1
• Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1
• Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)
• Efficacy and Safety of DHEA for Myotonic Dystrophy